Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Clinical trial NCT01853618 · COMPLETED
Trial details
- NCT number
- NCT01853618
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-02
- Primary completion
- 2017-06-07
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.